Drugs / TB/FLU-04L
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02501421 Comparator | Oct 2013 → Apr 2014 | tuberculosis | Research Institute for Biological Safety Problems | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TB/FLU-04L | “TB/FLU-04L” NCT02501421 ↗ |
| Modality | Vaccine | “Live recombinant influenza vectored tuberculosis vaccine” NCT02501421 ↗ |